Increased levels of IL-6 9-11, IL-1 12, IL-8 13, IL-12 and IL-18 14 have been reported in the plasma in ESCC patients and correlated to poor prognosis or adverse clinical (or pathological) changes in ESCC. The gene discussed is CXCL8; the disease is esophageal squamous cell carcinoma.